『Hematology / Oncology @Point of Care Podcasts』のカバーアート

Hematology / Oncology @Point of Care Podcasts

Hematology / Oncology @Point of Care Podcasts

著者： @Point of Care
無料で聴く

Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.Copyright 2020 At Point of Care, LLC. All rights reserved. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • S29:E1 – TROP2 ADCs in NSCLC: Mechanisms and Management

    S29:E1 – TROP2 ADCs in NSCLC: Mechanisms and Management
    2026/06/30

    In this episode, Dr. Kristen Marrone and nurse practitioner Beth Sandy discuss the mechanism and clinical evidence supporting TROP2-directed ADCs, emerging agents and combinations, and ongoing biomarker development to optimize patient selection.

    Visit TROP2 ADCs in NSCLC: Mechanisms and ManTROP2 ADCs in NSCLC: Mechanisms and Managementagement to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    続きを読む 一部表示
    34 分
  • S29:E2 – Managing Toxicities With TROP2-Targeting ADCs for NSCLC

    S29:E2 – Managing Toxicities With TROP2-Targeting ADCs for NSCLC
    2026/06/30

    In this episode, Dr. Kristen Marrone and nurse practitioner Beth Sandy discuss strategies for preventing the key adverse effects associated with datopotamab deruxtecan (Dato-DXd), including stomatitis, ocular toxicities, and drug-induced interstitial lung disease/pneumonitis.

    Visit Managing Toxicities With TROP2-Targeting ADCs for NSCLC to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.
    続きを読む 一部表示
    29 分
  • S28:E2 – Randomized Controlled Trials and Real-World Evidence: Efficacy Across Patient Subgroups with LR-MDS

    S28:E2 – Randomized Controlled Trials and Real-World Evidence: Efficacy Across Patient Subgroups with LR-MDS
    2026/04/24

    In this podcast episode, Andrew Kuykendall, MD, and Sangeetha Venugopal, MD, MS they review the clinical trial and real-world evidence on the efficacy and safety of currently available therapies for patients with lower-risk myelodysplastic syndrome (LR-MDS)-associated anemia. Their thought-provoking discussion will give an overview of the pertinent publications while highlighting the clinical implications of this data, in practice.

    Visit https://suitehome.atpointofcare.com/library/2729.02/page/0

    to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    続きを読む 一部表示
    30 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません